Mackichan J J, Pyszczynski D R, Jusko W J
Biopharm Drug Dispos. 1980 Apr-Jun;1(4):159-66. doi: 10.1002/bdd.2510010403.
The pharmacokinetics and relative systemic availability or oral propranolol were studied in three healthy volunteers following administration of 10, 40, and 80 mg of propranolol hydrochloride. Plasma concentrations of propranolol were determined using a sensitive and specific fluorometric high pressure liquid chromatographic technique. In the dosage range studied, the amount of propranolol reaching the systemic circulation increased with dose, while half-lives remained unchanged. The apparent 'threshold dose' for propranolol was much smaller than previously reported, and its contribution to the observed dose-dependent availability is doubtful. Apparent intrinsic clearance values were shown to decrease with increase in dose, with a true maximal intrinsic clearance of 5.4 l kg-1 h-1. These data suggest the saturation of a low capacity enzyme system in the liver and are consistent with theoretical characteristics of a drug that is extensively metabolized during its first pass through the liver.
在三名健康志愿者服用10毫克、40毫克和80毫克盐酸普萘洛尔后,对口服普萘洛尔的药代动力学及相对全身可用性进行了研究。使用灵敏且特异的荧光高压液相色谱技术测定血浆中普萘洛尔的浓度。在所研究的剂量范围内,进入体循环的普萘洛尔量随剂量增加而增加,而半衰期保持不变。普萘洛尔的表观“阈剂量”比先前报道的要小得多,其对观察到的剂量依赖性可用性的作用值得怀疑。表观内在清除率值显示随剂量增加而降低,真正的最大内在清除率为5.4升·千克⁻¹·小时⁻¹。这些数据表明肝脏中低容量酶系统的饱和,并且与一种在首次通过肝脏时被广泛代谢的药物的理论特征一致。